Water for Injection Market is Estimated to Develop at a CAGR of 9.5% during the Forecast Period, observes TMR Study

• Higher demand for generic medications is likely to boost the global market for water for injection during the forecast period
• Increasing occurrence of cardiovascular disorders and cancer is likely to boost the global market in the forthcoming years

Wilmington, Del., Aug. 4, 2022 /PRNewswire/ -- The value of the global water for injection market stood at US$ 21.5 Bn in 2021. The global market estimated to rise at a CAGR of 9.5% during the forecast period, from 2022 to 2031. The global water for injection market size is estimated to surpass value of US$ 53.8 Bn by 2031. Active pharmaceutical ingredients (APIs), pharmaceutical products, and intermediates are all processed, formulated, and manufactured utilizing water for injection as an ingredient, raw material, and solvent. Pharmacopeia Europa, the United States Pharmacopeia (USP), and other regulatory bodies have set quality requirements for sterile water utilized in the production of pharmaceutical goods. This includes using it to rinse containers, clean equipment, or serve as an analytical reagent (EP).

Water for injection market demand analysis predict that with the growth of the generic injectable and biopharmaceutical businesses, the demand for water for injection is anticipated to increase during the forecast timeframe. Most of the medications are used to treat cancer, heart disease, and diabetes are accessible as injectables. The global water for injection market is expected to be driven by new medication formulations, an increasing occurrence of cancer and cardiovascular disorders, and increasing healthcare access in developing markets.  Pharmaceutical bacteriostatic water needs to be produced, stored, and distributed utilizing systems that are properly commissioned, planned, built, and also appropriately maintained.

Get Exclusive PDF Sample Copy of Water for Injection Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84885 

Key Findings of Market Report

Vaccines, peptides, antibodies, biologics, enzymes, plasma, and proteins are amongst the medications that are in higher demand. The market for biopharmaceuticals has experienced rapid expansion in recent years, and this pattern is anticipated to hold during the forecast timeframe. As generic injectable and biopharmaceutical industries expand, there is likely to be an increase in demand for sterile water for injection since bacteriostatic water for injection is a crucial part of these fields.

The vast majority of drugs utilized to treat diabetes, cardiovascular disease, and cancer come in injectable dose forms. Rising demand for cancer treatment, new medication formulation, as well as improved accessibility to healthcare facilities in developing countries is expected to drive growth opportunities in water for injection in the years to come.

By 2031, the category of formulate parenteral drugs is expected to hold a considerable market share for water for injection, around 60% of the market. Generic parenteral formulations are developed more quickly than branded ones since there is no need to undertake toxicity assessments or clinical trials for them. A large influx of manufacturers providing low-cost substitutes for branded medications is likely to present immense growth opportunities for key players in the water for injection market. Consequently, parenteral formulations are being developed.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84885 

Global Water for Injection Market: Growth Drivers

There are substantial unfulfilled healthcare needs in the treatment of chronic diseases, which is what drives the biopharmaceutical business. In addition, the global market is projected to be driven by the patent expiry of branded biologic medications, which has made room for biosimilars, and widespread manufacturing of clinically effective medications.

In North America, there is a growing market for biopharmaceuticals to treat chronic illnesses including chronic renal diseases, neurological disorders, and cancer. As a result, the region's need for water for injection is increasing owing to the advancement of specialty enzymes and plasma fractionation.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84885

Global Water for Injection Market: Key Players

Some of the key market players are

• Johnson & Jonson Services, Inc.
• Serum Institute of India
• Baxter International, Inc.
• Thermo Fisher Scientific
• Sun Pharmaceutical Ltd.
• Merck KGaA

Global Water for Injection Market: Segmentation

Application

• Formulate Parenteral Drugs
• Solvent
• Cleaning Agents

End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Injection Pen Market: The global injection pen market was valued at US$ 3.2 Bn in 2019. It is projected to expand at a moderate CAGR from 2020 to 2030.

Syringes Market: The Europe syringes market expected to reach the value of US$ 6.9 Bn by the end of 2031. It is estimated to grow at a CAGR of 5.6% from 2022 to 2031.

Prefilled Syringes Market: The global prefilled syringes market is anticipated to reach more than US$ 35.7 Bn by the end of 2031.

Disposable Syringes Market: The disposable syringes market is expected to progress at a robust CAGR of ~7% during the forecast period.

Cell Culture Media, Sera, and Reagents Market: The global cell culture media, sera, and reagents market is expected to reach the value at US$ 18.3 Bn by the end of 2031.

Pharmaceutical Contract Sales Outsourcing Market: Rising focus of pharma companies on their core business activities is leading to profitable opportunities in the market.

Human Microbiome Market: The human microbiome market in India is anticipated to reach more than US$ 282 Mn by the end of 2031.

Venous Diseases Treatment Market: The global venous diseases treatment market is anticipated to reach more than US$ 11.3 Bn by 2031.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg